Skip to main content

Table 4 Odds ratios for the risk of IR in HFrEF and HFpEF groups compared to controls and between HF groups

From: Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension

Index

OR (CI 95%)

HFrEF vs controls

HFpEF vs controls

HFrEF vs HFpEF

HOMA-IR

4.00 (2.21–7.76) p < 0.001

2.81 (1.48–5.32) p < 0.001

1.43 (0.71–2.56) p > 0.05

I0/G0

2.91 (1.44–5.90) p < 0.05

2.41 (1.11–5.21) p < 0.05

1.21 (0.64–2.29) p > 0.05

I2/G2

2.03 (1.05–3.93) p < 0.05

1.64 (0.79–3.41) p > 0.05

1.24 (0.65–2.37) p > 0.05

QUICKI

3.49 (1.96–6.21) p < 0.001

2.76 (1.22–4.26) p < 0.01

1.53 (0.57–1.09) p > 0.05

  1. Numbers marked in bold indicate a significant OR (p < 0.05)
  2. HOMA-IR homeostatic model assessment of insulin resistance; I0/G0 plasma insulin/glucose ratio measured at fasting; I2/G2 plasma insulin/glucose ratio measured 2 h after glucose intake; QUICKI quantitative insulin-sensitivity check index; 95% CI confidence interval; OR odd ratio